Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes
Haloom Rafehi, Antony Kaspi, Mark Ziemann, Jun Okabe, Tom C Karagiannis, Assam El-Osta
Epigenetics | TAYLOR & FRANCIS INC | Published : 2017
We thank Dr. Ross Lazarus for bioinformatics support. We also acknowledge grant and fellowship support from the National Health and Medical Research Council (NHMRC). Supported in part by the Victorian Government's Operational Infrastructure Support Program.